NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/19/2025
Back to search
Official data from USPTO
LUNGOV
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
06/20/2025
Trademark type
Word
Nice classes
5
Filing date
06/21/2022
Registration date
10/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
06/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
MESSICK, TABITHA
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
XENOTHERA
Representatives
Ronald M. Kachmarik Cooper Legal Group, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceuticals products for use in human or veterinary medicine for the prevention and treatment of infectious diseases; chemical preparations for medical or pharmaceutical usefor the prevention and treatment of infectious diseases; diagnostic products for medical usediagnostic reagents and diagnostic biomarker reagents for use in human or veterinary medicine; chemical reagents for medical or veterinary use; monoclonal antibodies for medical and pharmaceutical use; pharmaceutical products and preparations for cell therapyfor the prevention and treatment of infectious diseases; biological preparations for use in human or veterinary medicinefor pharmaceutical use for prevention and treatment of infectious diseases; microorganism cultures for use in human or veterinary medicinefor pharmaceutical use; cell preparations for use in human or veterinary medicinefor pharmaceutical usein particular for gene therapy and cell therapy
Publications
History of USPTO decisions and trademark events.
26 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/26/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/05/2024
FIMP
FINAL DISPOSITION PROCESSED
02/05/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/31/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/31/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2023
GPNX
NOTIFICATION PROCESSED BY IB
08/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/15/2023
PUBO
PUBLISHED FOR OPPOSITION
08/15/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/02/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2023
RFNT
REFUSAL PROCESSED BY IB
06/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/21/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2023
RFRR
REFUSAL PROCESSED BY MPU
06/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/10/2023
CNRT
NON-FINAL ACTION WRITTEN
04/09/2023
DOCK
ASSIGNED TO EXAMINER
04/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/20/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/15/2022
Continuous trademark protection
Get notified about every new filing that threatens LUNGOV or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.